Navigation Links
K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva™
Date:7/13/2010

orn preterm tend to grow more slowly, have more problems with their eyes, ears, breathing and nervous system, and experience more learning and behavioral problems(3,4).  Preterm birth has been estimated to cost the United States more than $26 billion a year(5).

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a fully-integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded prescription products.  The Company markets its technology-distinguished products through Ther-Rx Corporation, its branded drug subsidiary.

For further information about K-V Pharmaceutical Company, please visit the Company's website at www.kvpharmaceutical.com.

Safe Harbor Statement

The information in this release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning the Company's operations, future results and prospects.  Such statements may be identified by the use of words like "plans," "expects," "aim," "believe," "projects," "anticipates," "commit," "intend," "estimate," "will," "should," "could," and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, statements about the number of preterm births for which Gestiva™ may be prescribed, its safety prof
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Ferring Pharmaceuticals FIRMAGON® Named Official Sponsor of Ed Randalls Bat for the Cure
2. Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc.
3. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
4. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
5. K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010
6. ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc.
7. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
8. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
9. Federal Appeals Court Rules Pharmaceutical Sales Reps Entitled to Overtime Pay
10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
11. EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and specialty ... consumers, employers and government health plans $23.3 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:2/26/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) ... Equipment - Global Strategic Business Report" report to ... worldwide markets for Radiation Therapy Equipment in US$ Million ... Systems, and Radiation Therapy Simulator. The report provides separate ... , Japan , Europe ...
(Date:2/26/2015)... 26, 2015 The report, ... washer, Filler, Capper, Blow molder, Shrink wrapper), Technology ... Flavored, Sparkling) & Region - Trends & Forecasts ... the bottled water processing market with analyses and ... of value. It also identifies the driving and ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4
... Immucor, Inc. (Nasdaq: BLUD ), a global leader in providing automated ... generation automated instrument, NEO™, has been cleared for marketing in the U.S. ... blood bank instrument designed to meet the needs of high volume laboratories. ... "We believe there is ...
... April 30 A new study, presented at the American Society ... Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of ... , , ... in several other studies to improve breast cancer detection and aid in ...
Cached Medicine Technology:Immucor Announces FDA Clearance of NEO, the Company's Fourth Generation Automated Instrument 2BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy 2
(Date:2/26/2015)... (PRWEB) February 26, 2015 Dr. Parsa Mohebi, ... his hair transplant contest winner’s surgery on Friday, ... winner Marc R., is all set to receive his grand ... ARTAS system. His procedure will be done on a live ... To watch the surgery, go to the website and experience ...
(Date:2/26/2015)... Chicago, IL (PRWEB) February 26, 2015 ... a small step to fund powerful progress for the ... season by raising critical funds and awareness that will ... adults fighting muscle disease. , “MDA Muscle Walk events ... progress for people whose abilities to move are compromised ...
(Date:2/26/2015)... PartnerTech Inc . has announced it has ... finalist. , The Movers & Makers Awards are ... processing, or distribution of tangible products and will be held ... event serves as Georgia’s largest local awards ceremony for manufacturing ... than 300 local industry and business leaders. , “We ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The COR ... Topical BioMedics, Inc., Rhinebeck, NY, to offer customers a ... topical biomedicine formulas that safely and effectively address muscle, ... new division of Vets Access LLC, Montrose, MI, that ... healing products. , Topical BioMedics is a research and ...
(Date:2/26/2015)... In a nested-case control study of individuals living in the ... incidence of liver cancer, statin use is associated with a ... study published February 26 in the JNCI: Journal of ... this association but most used data from individuals living in ... Asia. Katherine A. McGlynn, Ph.D., from the Division of Cancer ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3
... in the USA from recycled plastic bottles, the new Airnamic Green ... effectively removes dust, pet dander, grass and tree pollen, mold spores ... of plastic drink bottles provides consumers with an anti-microbial, moisture resistant, ... , ...
... magazine providing news and commentaries on issues that affect the ... workplace for an audience of predominantly African-American professionals, corporate executives ... Black Women in Business." , ... ...
... their newest hair loss video diaries and hair growth comparisons. The results ... video. , ... London, UK (PRWEB) February 11, 2009 -- For six ... user with video diaries. Diya Lababidi has been using one of Belgravia,s ...
... 10 Nationwide Health Properties, Inc. (NYSE: NHP ... M. Pasquale as Chairman of the Board and Robert D. ... Mr. Paulson are currently directors. These appointments will take ... Mr. Pasquale will succeed Charles D. Miller, who will remain ...
... Feb. 10 Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported significantly ... December 31, 2008. Highlights: , , , ... Third quarter net income increases 8% , ... , , For the third quarter of fiscal ...
... Feb. 10 Hanger Orthopedic Group, Inc. (NYSE: ... quarter ended December 31, 2008, an increase of $14.7 million, ... quarter. Pre-tax income increased $3.0 million, or 29.8%, to ... in the same quarter last year.Pro forma net income applicable ...
Cached Medicine News:Health News:Can a New Green Product Made From Recycled Plastic Soda Bottles Provide Cleaner Indoor Air and a Healthier Home? 2Health News:The Network Journal Announces it's 2009 List of "25 Influential Black Women in Business" 2Health News:The Network Journal Announces it's 2009 List of "25 Influential Black Women in Business" 3Health News:Best Hair Loss Treatment Results Ever Captured on Video? 2Health News:Best Hair Loss Treatment Results Ever Captured on Video? 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 9Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 10
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple, intuitive ...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... supply, with temperature probe, 100-120 and 220-240 V, ... mA, and 400 W. The temperature probe is ... 90 degrees C during electrophoresis. Built-in infrared capability ... instructions are provided. Dimensions are 27.5 x 34 ...
Medicine Products: